Global Human Microbiome Market, by Product Type (Foods, Diagnostic Devices/Kits, Drugs, and Others), by Application (Therapeutics and Diagnostics), by Disease Indication (Gastrointestinal Disorders, Metabolic Disorders, Women Health, Cancer, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 46,913.4 million in 2017, and is projected to exhibit a CAGR of 17.5% over the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights.
High number of collaboration activities between key players and academia
Increasing number of collaboration activities between various players in the market and between different players and research institutes is expected to aid in the expansion and development of novel medicines for variety of diseases. For instance, in 2017, AOBiome secured US$ 30 million investment for advancing clinical research on systemic and topical inflammatory disorders using novel bacterial platform from iCarbonX. It is evident that such efforts are accelerating the research and development of microbiome platform.
Similarly, in 2017, Stanford University School of Medicine and Vedanta Biosciences Inc. entered in research collaboration to focus on food allergies in children and on patients with C. difficile infection or graft-versus-host disease
Browse 36 Market Data Tables and 35 Figures spread through 220 Pages and in-depth TOC on ‘Human Microbiome Market’- Global Forecast to 2026, by Product Type (Foods, Diagnostic Devices/Kits, Drugs, and Others), by Application (Therapeutics, and Diagnostics), by Disease Indication (Gastrointestinal Disorders, Metabolic Disorders, Women Health, Cancer, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) To know the latest trends and insights prevalent in the Human Microbiome market, click the link below:
Growing incidence of disease conditions in which human microbiome product is used. According to data given by Centre for Disease Control and Prevention in October 2017, Clostridium difficile infection (CDI) is one of the most common healthcare-associated infections in the China and Hong Kong, affecting around 36.1 cases/100,000 person in 2014, an annual increase of 26%. According to study published in Clinical Infectious Disease journal in 2015, about 25% to 33% of antibiotic-associated diarrhea and 90% of pseudomembranous enteritis are caused by CDI.
Key Takeaways of the Human Microbiome Market:
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.